These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 8132376)
1. Safety and efficacy of ciprofloxacin in paediatric patients--review. Kubin R Infection; 1993; 21(6):413-21. PubMed ID: 8132376 [TBL] [Abstract][Full Text] [Related]
2. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group. Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118 [TBL] [Abstract][Full Text] [Related]
3. Tolerance and safety of ciprofloxacin in paediatric patients. Black A; Redmond AO; Steen HJ; Oborska IT J Antimicrob Chemother; 1990 Dec; 26 Suppl F():25-9. PubMed ID: 2292542 [TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group. Richard DA; Nousia-Arvanitakis S; Sollich V; Hampel BJ; Sommerauer B; Schaad UB Pediatr Infect Dis J; 1997 Jun; 16(6):572-8. PubMed ID: 9194107 [TBL] [Abstract][Full Text] [Related]
5. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study]. Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847 [TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal. LeBel M Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):316-24. PubMed ID: 1907546 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report. Hampel B; Hullmann R; Schmidt H Pediatr Infect Dis J; 1997 Jan; 16(1):127-9; discussion 160-2. PubMed ID: 9002122 [TBL] [Abstract][Full Text] [Related]
8. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning. Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112 [TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis. Rubio TT Diagn Microbiol Infect Dis; 1990; 13(2):153-5. PubMed ID: 2114953 [No Abstract] [Full Text] [Related]
10. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation. Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120 [TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin therapy in cystic fibrosis. Scully BE; Nakatomi M; Ores C; Davidson S; Neu HC Am J Med; 1987 Apr; 82(4A):196-201. PubMed ID: 3555036 [TBL] [Abstract][Full Text] [Related]
12. Use of ciprofloxacin in cystic fibrosis patients. Bosso JA Am J Med; 1989 Nov; 87(5A):123S-127S. PubMed ID: 2589355 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study. Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118 [TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Schaad UB; Wedgwood J; Ruedeberg A; Kraemer R; Hampel B Pediatr Infect Dis J; 1997 Jan; 16(1):106-11; discussion 123-6. PubMed ID: 9002119 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis. Jensen T; Pedersen SS; Nielsen CH; Høiby N; Koch C J Antimicrob Chemother; 1987 Oct; 20(4):585-94. PubMed ID: 3479420 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E; Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983 [TBL] [Abstract][Full Text] [Related]
17. Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones. Stockmann C; Sherwin CM; Zobell JT; Young DC; Waters CD; Spigarelli MG; Ampofo K Pediatr Pulmonol; 2013 Mar; 48(3):211-20. PubMed ID: 22949224 [TBL] [Abstract][Full Text] [Related]
18. Treatment of serious infections with intravenous ciprofloxacin. Scully BE; Neu HC Am J Med; 1987 Apr; 82(4A):369-75. PubMed ID: 3555062 [TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin in the treatment of acute and chronic osteomyelitis: a review. Norrby SR Scand J Infect Dis Suppl; 1989; 60():74-8. PubMed ID: 2667110 [TBL] [Abstract][Full Text] [Related]
20. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]